Axitinib in Metastatic Renal Cell Carcinoma Patients With Favorable Prognostic Factors
Clinical trial NCT02700568 · COMPLETED
Trial details
- NCT number
- NCT02700568
- Sponsor
- Kidney Cancer Research Bureau
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2018-06-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.